Kenya has achieved low middle-income status and, as per the GAVI Alliance policy, is expected to transition out of GAVI support by 2027. The period 2017/18 to 2021/22 is the preparatory transition phase that will be followed by a 5-year accelerated transition phase (2022/23- 2025/26); during this period, the domestic funding obligations will systematically increase. The country will have to fully finance the immunization program from 2026/27.
As part of the preparatory transition phase, it is essential to initiate strategic discussions on ensuring predictable domestic funding for immunization to allow the country to meet its obligations during the accelerated GAVI transition phase and sustain immunization activities. This situation raised the issue of how to harness local resources for NVIP activities adequately and how the program positions itself in this changing environment.
This work generates information that will identify the main local and international actors supporting immunization activities and describe the financing mechanisms for these activities. It will also allow stakeholders to see where they are relative to others and NVIP objectives, their positions, and contributions.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.